DNA Methylation-Based Measures of Biological Age Predict Mortality
Across 13 studies and over 13,000 people, a DNA methylation-based epigenetic age older than your actual age predicted a higher risk of death, independent of traditional risk factors.
KEY FINDINGS
Led by Brian Chen and Riccardo Marioni, this meta-analysis pooled data from 13 cohorts across three racial and ethnic groups, 13,089 people in total, to test whether "epigenetic age", a biological age estimate derived from DNA methylation patterns, predicts mortality beyond a person's actual chronological age. It was published in the journal Aging in 2016 and built on earlier work showing DNA methylation age predicts mortality in older adults.
Every measure of epigenetic age acceleration tested was predictive of mortality, independent of chronological age, and the association held even after adjusting for additional clinical risk factors. Epigenetic age estimates that also accounted for blood cell composition were the strongest predictors of time to death of all the measures tested.
Earlier related research (Marioni et al., 2015) had already found that each 5-year gap between a person's epigenetic age and their actual age was associated with a 21% higher risk of death, even after adjusting for childhood IQ, education, social class and existing conditions like diabetes and cardiovascular disease.
The reason biological age is worth taking seriously sits in this finding. An epigenetic clock that runs ahead of a person's actual age predicts a higher risk of death, and it does so on top of the risk factors clinicians already measure, not merely as a restatement of them.
That independence is the point. It suggests the clock captures something real about how a body is ageing that standard markers miss, which is why it is worth establishing early and watching over time rather than reading just once.
